Garden Stage (GSIW) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Operates as a holding company incorporated in the Cayman Islands, with all operations conducted through wholly-owned subsidiaries in Hong Kong focused on financial services.
Provides placing and underwriting, securities dealing and brokerage, asset management, and investment advisory services through licensed subsidiaries.
No operations, offices, or personnel in Mainland China; does not utilize a VIE structure.
Revenues for the years ended March 31, 2024 and 2023 were $1.4 million and $3.3 million, respectively, with net losses of $4.7 million and $0.2 million.
Plans to grow by strengthening core services, expanding U.S. market presence, and developing asset management and margin financing.
Financial performance and metrics
Revenue declined from $3.3 million in FY 2023 to $1.4 million in FY 2024.
Net loss increased from $0.2 million in FY 2023 to $4.7 million in FY 2024.
No dividends or distributions have been made to shareholders or between the holding company and subsidiaries as of the prospectus date.
Market value of public float as of December 3, 2024, was approximately $3.65 million, based on 5,986,920 shares at $0.61 per share.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used as indicated in applicable prospectus supplements.
No current plans to declare or pay dividends; future earnings intended to finance business expansion.
Cash transfers between the holding company and subsidiaries are currently unrestricted under Cayman Islands and Hong Kong law, but may be subject to future PRC intervention.
Latest events from Garden Stage
- Revenue surged but losses widened on higher costs; major capital raise and acquisition announced.GSIW
H1 202620 Jan 2026 - Hong Kong-based financial group targets $100M shelf offering amid regulatory and market risks.GSIW
Registration Filing16 Dec 2025 - Form F-3 enables ongoing U.S. offerings, led by Sze Ho Chan, with robust governance.GSIW
Registration Filing16 Dec 2025 - FY2024 revenue dropped 56.8% and net loss widened to $4.6M amid lower deal flow and higher costs.GSIW
H2 202412 Dec 2025 - Resale of 1,750,000 shares by the controlling shareholder, no proceeds to the company.GSIW
Registration Filing29 Nov 2025 - Resale of 1,750,000 shares by a controlling shareholder amid regulatory and financial headwinds.GSIW
Registration Filing29 Nov 2025